Blog
RSS FeedPosted by Michael Wonder on 04 Mar 2021
PHARMAC swapping epilepsy drugs 'cannot be discounted' as a cause of deaths — neurologist
4 March 2021 - An Auckland paediatric neurologist says PHARMAC's decision to switch to a generic version of an epilepsy drug ...
Posted by Michael Wonder on 24 Feb 2021
PHARMAC knew of epilepsy drug change risks - inquest
24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their ...
Posted by Michael Wonder on 24 Feb 2021
PHARMAC knew of epilepsy drug change risks within some patients, but went ahead with switch
24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their medicines. ...
Posted by Michael Wonder on 23 Feb 2021
Epilepsy drug deaths: Medsafe told PHARMAC it was 'not desirable' to switch brands
23 February 2021 - The medicines safety authority advised PHARMAC it was “not desirable” for patients to switch brands of ...
Posted by Michael Wonder on 22 Feb 2021
Maker of epilepsy drug warned over quality control
23 February 2021 - The drug at the centre of an inquest into six epilepsy deaths was made at a plant ...
Posted by Michael Wonder on 21 Feb 2021
Epilepsy drug deaths: Coronial inquiry into medication-linked deaths resumes
22 February 2021 - A coronial inquiry into the deaths of six patients whose epilepsy medication was changed before they ...
Posted by Michael Wonder on 14 Feb 2021
Does NICE influence the adoption and uptake of generics in the UK?
14 February 2021 - The aim of this paper is to examine generic competition in the UK, with a special focus ...
Posted by Michael Wonder on 11 Feb 2021
FDA’s generic drug program in 2020 helped ensure availability of high quality, affordable drugs amid COVID-19
11 February 2021 - Generic drugs play a vital role in facilitating access to lifesaving medicines for Americans and remain a ...
Posted by Michael Wonder on 17 Jan 2021
Billionaire Mark Cuban wants to lower drug prices with generics startup
15 January 2021 - Billionaire Mark Cuban is mad about the high cost of prescription drugs in the United States, ...
Posted by Michael Wonder on 14 Jan 2021
Amneal launches generic abiraterone acetate 500 mg tablets following ANDA approval by FDA
8 January 2021 - Amneal Pharmaceuticals announced that it has received approval of an additional strength of 500 mg to its ...
Posted by Michael Wonder on 29 Dec 2020
FDA approves first generic of drug used to treat severe hypoglycaemia
28 December 2020 - Today, the U.S. FDA approved the first generic of glucagon for injection USP, 1 mg/vial packaged in ...
Posted by Michael Wonder on 20 Dec 2020
Hikma launches generic Advair Diskus following FDA approval
17 December 2020 - Hikma Pharmaceuticals announces it has received FDA approval for and launched its generic version of GlaxoSmithKline’s ...
Posted by Michael Wonder on 17 Dec 2020
FDA updates list of off-patent, off-exclusivity drugs without an approved generic
17 December 2020 - Today, the U.S. FDA published an update to the “List of Off-Patent, Off-Exclusivity Drugs without an Approved ...
Posted by Michael Wonder on 30 Nov 2020
GPs tell inquest they were unaware PHARMAC changed their patients' epilepsy drugs
30 November 2020 - Two GPs caring for patients who died after switching brands of an epilepsy drug say they were ...
Posted by Michael Wonder on 29 Nov 2020
Sudden epilepsy deaths: grieving mum speaks out ahead of coronial inquest
28 November 2020 - Michelle Townes believes her 31-year-old son died because the brand of his Government funded drug was switched. ...